Synopsis
In the center of the recent Tribeca Film Festival scandal surrounding his film VAXXED: From Cover-up to Controversy stands Andrew Wakefield, discredited and stripped of his medical license for his infamous study suggesting a link between the MMR vaccine, bowel disease, and autism. THE PATHOLOGICAL OPTIMIST takes us into the inner sanctum of Wakefield and his family from 2011- 2016 as he fights for his day in court in a little known defamation case against the British Medical Journal. Wakefield attempts to clear his name as the media-appointed Father of the Anti-vaccine movement. Director Miranda Bailey weaves a delicate portrait of a man who is THE PATHOLOGICAL OPTIMIST utilizing a never-before-seen, full access look at the man at the center of one of the biggest medical and media controversies of our times.
Scores
Popularity Percentile (Year)
6.6%
Box Office Percentile (Year)
11.5%
Critic Consensus
60.0% Fresh • 5 critic reviews
Critic reception is mixed, with 60% of 5 logged reviews marked Fresh. Across reviews, critics repeatedly emphasize character-driven, emotional, visually striking. Common reservations focus on uneven tone, even when reviewers praise standout elements.
character-drivenemotionalvisually strikingthought-provokingrealisticuneven tone
Cast
| Cast | Year | Reported Salary | Inflation Adjusted | Notes |
|---|
| N/A |
Aggregated Reviews
Rotten Tomatoes critic score60.0
RT critic review count5
Rotten Tomatoes audience score85.0
RT audience rating count50
IMDb rating4.8
IMDb votes181
Box Office ?
| Category | Year | Reported | Inflation Adjusted |
|---|
| Domestic | 2017 | $11,222 | $14,363 |
| International | 2017 | N/A | N/A |
| Worldwide | 2017 | $11,222 | $14,363 |
Earnings / Profitability
Estimated net revenues and net expenses for films based on reported and estimated numbers. This income statement should be considered most viable for the first 24 months after the inital movie's release (ie after most lucrative pay windows).
| Category | Year | Reported | Inflation Adjusted |
|---|
| Revenues |
| Theatrical Net Revenue | 2017 | $5,611 | $7,181 |
| Digital Rentals ? | 2017 | $337,000 | $431,322 |
| Digital Purchases ? | 2017 | $376,000 | $481,237 |
| Physical Rentals ? | 2017 | $252,000 | $322,531 |
| Physical Purchases ? | 2017 | $723,000 | $925,357 |
| TV & Streaming Revenue | 2017 | $59,400 | $76,025 |
| Total Revenues | 2017 | $1,753,011 | $2,243,654 |
| Expenses |
| Budget ? | 2017 | $198,000 (est) | $253,417 (est) |
| Print & Advertising (P&A) ? | 2017 | $80,000 (est) | $102,391 (est) |
| Participations | 2017 | $70,000 | $89,592 |
| Residuals ? | 2017 | $88,000 | $112,630 |
| Interest & Overhead | 2017 | $39,600 | $50,683 |
| Total Expenses | 2017 | $475,600 | $608,714 |
| Movie Net Profit or Loss | 2017 | $1,277,411 | $1,634,940 |
Similar Movies
| Poster | Movie | Year | Match | Overall | Est. Profit |
|---|
 | Won't You Be My Neighbor? | 2018 | Shared genres: 2 | 81.8 | $15,069,865 |
 | Three Identical Strangers | 2018 | Shared genres: 2 | 81.2 | $14,259,486 |
 | Amy | 2015 | Shared genres: 2 | 80.1 | $22,715,889 |
 | Searching for Sugar Man | 2012 | Shared genres: 2 | 77.4 | $23,551,234 |
 | Senna | 2011 | Shared genres: 2 | 75.3 | $18,376,079 |
Tooltips
- Budget Estimated using Machine Learning
- Digital Rentals: PVOD, VOD, & On-Demand
- Marketing & distribution costs to release Movie in Theaters. Includes: Online & Offline Ads, Posters, Trailer Production, and physical or digital copies (formerly "prints") sent to cinemas.
- Net Digital Purchase Revenue
- Net Revenues for Physical Rentals: VHS, DVD, BluRay (when appropriate)
- Physical Purchases: VHS $0, DVD $466,000, BluRay $256,000
- Reported or Estimated Net Budget (after tax, product placements, & grants)
- Theatrical box office grosses split into Domestic, International, and Worldwide totals.
- Union-modeled residuals using SAG-AFTRA and WGA schedules as a simplified estimate proxy.
- reestimate_prior_estimate;covid_mult=1.00;peer_count=0;reg_box_pred=41887;reg_main_pred=198905
Budget Tooltip
Reported or Estimated Net Budget (after tax, product placements, & grants)
Comments
No approved comments yet.